N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement.

Yu J, Wang W

Open source

DOI
10.1186/s13019-023-02391-2
Published
2023 Oct 10
Container
Journal of cardiothoracic surgery
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13019-023-02391-2,
  title = {N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement.},
  author = {Yu J and Wang W},
  year = {2023},
  journal = {Journal of cardiothoracic surgery},
  doi = {10.1186/s13019-023-02391-2},
  url = {https://doi.org/10.1186/s13019-023-02391-2}
}

RIS

TY  - JOUR
TI  - N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement.
AU  - Yu J
AU  - Wang W
PY  - 2023
JO  - Journal of cardiothoracic surgery
DO  - 10.1186/s13019-023-02391-2
UR  - https://doi.org/10.1186/s13019-023-02391-2
ER  - 

APA

J, Y., & W, W. (2023). N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement.. Journal of cardiothoracic surgery. https://doi.org/10.1186/s13019-023-02391-2

Source records